Denise Mazess Herpai

Title: Innovations and Contributions of Denise Mazess Herpai

Introduction

Denise Mazess Herpai is a prominent inventor based in Winston-Salem, NC (US). She has made significant contributions to the field of cancer research, holding a total of 9 patents. Her work focuses on developing innovative methods for detecting and treating various types of cancers.

Latest Patents

Among her latest patents is the invention titled "Molecular signature of cancer." This invention provides compounds, compositions, and methods for detecting, diagnosing, and treating cancers such as glioblastoma multiforme. Another notable patent is for "Antibodies against human and canine IL-13RA2." This patent includes monoclonal antibodies that specifically bind IL-13RA2 with cross-reactivity in humans and canines. The methods of use for these antibodies are aimed at the treatment and monitoring of cancers.

Career Highlights

Denise is affiliated with Wake Forest University, where she continues her research and development efforts. Her work has garnered attention in the scientific community, contributing to advancements in cancer treatment methodologies.

Collaborations

Denise collaborates with esteemed colleagues such as Waldemar Debinski and Jill Wykosky, enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Denise Mazess Herpai's innovative work in cancer research exemplifies her dedication to improving diagnostic and treatment options for patients. Her contributions are vital in the ongoing fight against cancer, showcasing the importance of innovation in medical science.